TW200619389A - Process for preparing the enantiomeric forms of cis-configured 3-hydroxycyclohexanecarboxylic acid derivatives - Google Patents
Process for preparing the enantiomeric forms of cis-configured 3-hydroxycyclohexanecarboxylic acid derivativesInfo
- Publication number
- TW200619389A TW200619389A TW094126457A TW94126457A TW200619389A TW 200619389 A TW200619389 A TW 200619389A TW 094126457 A TW094126457 A TW 094126457A TW 94126457 A TW94126457 A TW 94126457A TW 200619389 A TW200619389 A TW 200619389A
- Authority
- TW
- Taiwan
- Prior art keywords
- cis
- preparing
- acid derivatives
- enantiomeric forms
- hydroxycyclohexanecarboxylic acid
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- JBZDHFKPEDWWJC-UHFFFAOYSA-N 3-hydroxycyclohexane-1-carboxylic acid Chemical class OC1CCCC(C(O)=O)C1 JBZDHFKPEDWWJC-UHFFFAOYSA-N 0.000 title 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical class OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 abstract 1
- HPXRVTGHNJAIIH-PTQBSOBMSA-N cyclohexanol Chemical class O[13CH]1CCCCC1 HPXRVTGHNJAIIH-PTQBSOBMSA-N 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004038403A DE102004038403B4 (de) | 2004-08-07 | 2004-08-07 | Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 3-Hydroxycyclohexancarbonsäure-Derivaten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200619389A true TW200619389A (en) | 2006-06-16 |
Family
ID=35610188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094126457A TW200619389A (en) | 2004-08-07 | 2005-08-04 | Process for preparing the enantiomeric forms of cis-configured 3-hydroxycyclohexanecarboxylic acid derivatives |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20070197788A1 (zh) |
| EP (1) | EP1805316B1 (zh) |
| JP (1) | JP2008509102A (zh) |
| KR (1) | KR20070041564A (zh) |
| CN (1) | CN1989253A (zh) |
| AR (1) | AR050100A1 (zh) |
| AT (1) | ATE428795T1 (zh) |
| AU (1) | AU2005270447A1 (zh) |
| CA (1) | CA2576080A1 (zh) |
| DE (2) | DE102004038403B4 (zh) |
| DK (1) | DK1805316T3 (zh) |
| ES (1) | ES2324945T3 (zh) |
| IL (1) | IL180873A0 (zh) |
| MX (1) | MX2007000996A (zh) |
| PT (1) | PT1805316E (zh) |
| TW (1) | TW200619389A (zh) |
| UY (1) | UY29053A1 (zh) |
| WO (1) | WO2006015716A2 (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004040736B4 (de) * | 2004-08-23 | 2007-01-11 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung von Diarylcycloalkylderivaten |
| AR108838A1 (es) | 2016-06-21 | 2018-10-03 | Bristol Myers Squibb Co | Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa |
| CN108456213B (zh) * | 2017-02-22 | 2021-01-15 | 浙江九洲药业股份有限公司 | 一种3-氟-4-羟基环己烷羧酸酯的制备方法 |
| ES2938863T3 (es) | 2017-12-19 | 2023-04-17 | Bristol Myers Squibb Co | Triazol azoles de ácido ciclohexilo como antagonistas de ácido lisofosfatídico (LPA) |
| US11180488B2 (en) | 2017-12-19 | 2021-11-23 | Bristol-Myers Squibb Company | Isoxazole o-linked carbamoyl cyclohexyl acids as LPA antagonists |
| CN112055711A (zh) | 2017-12-19 | 2020-12-08 | 百时美施贵宝公司 | 作为lpa拮抗剂的环己基酸三唑吖嗪类 |
| EA202091506A1 (ru) | 2017-12-19 | 2020-09-22 | Бристол-Маерс Сквибб Компани | Триазол n-связанные карбамоил циклогексильные кислоты в качестве антагонистов lpa |
| CA3085347A1 (en) | 2017-12-19 | 2019-06-27 | Bristol-Myers Squibb Company | Pyrazole n-linked carbamoyl cyclohexyl acids as lpa antagonists |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0469375A (ja) * | 1990-07-06 | 1992-03-04 | Sankyo Co Ltd | 光学活性なシクロヘキシルカルボキシラート類及びその製法 |
| DE10004926A1 (de) * | 2000-02-04 | 2001-08-09 | Gruenenthal Gmbh | Verfahren zur enzymatischen Racematspaltung von Aminomethyl-Aryl-Cyclohexanol-Derivaten |
| CA2458210C (en) * | 2001-08-31 | 2011-09-20 | Aventis Pharma Deutschland Gmbh | Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar-activators |
| DE10308350B4 (de) * | 2003-02-27 | 2006-06-01 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 1,3-Cyclohexandiol-Derivaten |
| US7173151B2 (en) * | 2003-02-27 | 2007-02-06 | Sanofi-Aventisdeutschand Gmbh | Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals |
| DE10308355A1 (de) * | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
-
2004
- 2004-08-07 DE DE102004038403A patent/DE102004038403B4/de not_active Expired - Fee Related
-
2005
- 2005-07-23 DE DE502005007103T patent/DE502005007103D1/de active Active
- 2005-07-23 CA CA002576080A patent/CA2576080A1/en not_active Abandoned
- 2005-07-23 EP EP05778085A patent/EP1805316B1/de not_active Not-in-force
- 2005-07-23 AT AT05778085T patent/ATE428795T1/de not_active IP Right Cessation
- 2005-07-23 MX MX2007000996A patent/MX2007000996A/es active IP Right Grant
- 2005-07-23 CN CNA2005800253076A patent/CN1989253A/zh active Pending
- 2005-07-23 JP JP2007524225A patent/JP2008509102A/ja not_active Abandoned
- 2005-07-23 WO PCT/EP2005/008058 patent/WO2006015716A2/de active Application Filing
- 2005-07-23 KR KR1020077002917A patent/KR20070041564A/ko not_active Application Discontinuation
- 2005-07-23 PT PT05778085T patent/PT1805316E/pt unknown
- 2005-07-23 DK DK05778085T patent/DK1805316T3/da active
- 2005-07-23 AU AU2005270447A patent/AU2005270447A1/en not_active Abandoned
- 2005-07-23 ES ES05778085T patent/ES2324945T3/es active Active
- 2005-08-04 AR ARP050103251A patent/AR050100A1/es not_active Application Discontinuation
- 2005-08-04 TW TW094126457A patent/TW200619389A/zh unknown
- 2005-08-05 UY UY29053A patent/UY29053A1/es unknown
-
2007
- 2007-01-22 IL IL180873A patent/IL180873A0/en unknown
- 2007-01-31 US US11/669,545 patent/US20070197788A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE428795T1 (de) | 2009-05-15 |
| AU2005270447A1 (en) | 2006-02-16 |
| PT1805316E (pt) | 2009-07-06 |
| DE102004038403A1 (de) | 2006-02-23 |
| WO2006015716A3 (de) | 2006-06-22 |
| DK1805316T3 (da) | 2009-08-10 |
| US20070197788A1 (en) | 2007-08-23 |
| DE102004038403B4 (de) | 2006-08-31 |
| CA2576080A1 (en) | 2006-02-16 |
| CN1989253A (zh) | 2007-06-27 |
| MX2007000996A (es) | 2007-04-16 |
| DE502005007103D1 (de) | 2009-05-28 |
| AR050100A1 (es) | 2006-09-27 |
| JP2008509102A (ja) | 2008-03-27 |
| ES2324945T3 (es) | 2009-08-20 |
| KR20070041564A (ko) | 2007-04-18 |
| WO2006015716A2 (de) | 2006-02-16 |
| EP1805316B1 (de) | 2009-04-15 |
| UY29053A1 (es) | 2006-02-24 |
| IL180873A0 (en) | 2007-07-04 |
| EP1805316A2 (de) | 2007-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200619389A (en) | Process for preparing the enantiomeric forms of cis-configured 3-hydroxycyclohexanecarboxylic acid derivatives | |
| WO2006130657A3 (en) | Stereoselective reduction process for the preparation of pyrrolotriazine compounds | |
| WO2006016178A8 (en) | Enantioselective process | |
| WO2005082907A3 (de) | Pyrazolopyrimidine zur bekämpfung unerwünschter mikroorganismen | |
| BR0313070A (pt) | Métodos para preparação de um diastereÈmero desejado de uma tetraidro-beta-carbolina e para preparação de um composto | |
| HK1074059A1 (en) | Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives | |
| MXPA05007883A (es) | Proceso para producir una preparacion recubierta. | |
| WO2006021379A8 (de) | Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| WO2006021378A8 (de) | Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| HK1095336A1 (en) | Oxidoreductase from pichia capsulata | |
| WO2007135188A3 (en) | Process for the preparation of l-methionine | |
| WO2006024387A3 (de) | Biphenylthiazolcarboxamide | |
| WO2007133184A3 (en) | Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors | |
| SG164381A1 (en) | Enzymatic production of (meth)acrylic acid esters | |
| PL1851322T3 (pl) | Sposób enancjoselektywnej redukcji enzymatycznej związków ketonowych | |
| WO2009056707A8 (fr) | Dérivés de l'ind0l-2-0ne disubstitues en 3, leur preparation et leur application en thérapeutique | |
| WO2006061215A3 (de) | 2-alkyl-cycloalk(en)yl-carboxamide | |
| TW200612959A (en) | Method for preparing hydroxamic acids | |
| MY151183A (en) | Processes for the preparation of 4-oxo-octahydro-indole-1-carbocyclic acid methyl ester and derivatives thereof | |
| IL183449A0 (en) | Process for the preparation of carvedilol and its enantiomers | |
| WO2010053950A3 (en) | Biosynthesis of styrene and 7-methyl-1,3,5-cyclooctatriene | |
| TW200738650A (en) | Process for synthesis of aryloxy diaminopyrimidines | |
| WO2007093877A8 (en) | Process for over-production of hydrogen | |
| DE102005054282A1 (de) | Verfahren zur Herstellung von überwiegend ein Enantiomer enthaltendem 1,1,1-Trifluorisopropanol | |
| GEP20156422B (en) | Method for enzymatic synthesis of (7s)-1-(3,4-dimethoxybicyclo [4.2.0]octa-1,3,5-triene-7-yl)n-methyl methanamine and application therein ivabradine synthesis |